Sreedhar Subramanian

A biomarker-stratified comparison of top-down versus accelerated step-up treatment strategies for patients with newly diagnosed Crohn's disease (PROFILE): a multicentre, open-label randomised controlled trial

Nurulamin M Noor, James Lee, Simon Bond et al. · ˜The œLancet. Gastroenterology & hepatology · 2024 · 229 citations · Full text

A Randomized, Double-blind, Placebo-controlled, Parallel-group, Pilot Study of Cannabidiol-rich Botanical Extract in the Symptomatic Treatment of Ulcerative Colitis

Peter M. Irving, Tariq Iqbal, Chuka Nwokolo et al. · Inflammatory Bowel Diseases · 2018 · 149 citations

Mercaptopurine versus placebo to prevent recurrence of Crohn's disease after surgical resection (TOPPIC): a multicentre, double-blind, randomised controlled trial

Craig Mowat, Ian Arnott, Aiden Cahill et al. · ˜The œLancet. Gastroenterology & hepatology · 2016 · 105 citations · Full text

Replication of Colonic Crohn's Disease Mucosal <i>Escherichia coli</i> Isolates within Macrophages and Their Susceptibility to Antibiotics

Sreedhar Subramanian, Carol L. Roberts, C. Anthony Hart et al. · Antimicrobial Agents and Chemotherapy · 2007 · 91 citations · Full text

Characterization of epithelial IL-8 response to inflammatory bowel disease mucosal E. coli and its inhibition by mesalamine

Sreedhar Subramanian, Jonathan M. Rhodes, Anthony C. Hart et al. · Inflammatory Bowel Diseases · 2007 · 87 citations · Full text